Skip to main content

CaviWipes 2.0

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. 

Features and Benefits

  • Proven effective against SARS-CoV-2 on hard non-porous surfaces
  • Enhanced Efficacy Claims - Effective against over 40 pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
  • Excellent Material Compatibilty - Compatible with most non-porous, hard surfaces commonly used in clinical settings
  • Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more
  • 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)

Kill Claims

2-Minute Efficacy Against2

Bacteria
  • Staphylococcus aureus
  • Pseudomonas aeruginosa
  • Salmonella enterica
  • Legionella pneumophila
  • Bordetella pertussis
  • Moraxella catarrhalis
  • Enterococcus faecium
  • Klebsiella pneumoniae
  • Acinetobacter baumannii
  • Escherichia coli O157:H7
  • Micrococcus luteus
  • Streptococcus mutans
  • Burkholderia cepacia
  • Stenotrophomonas maltophilia
  • Streptococcus pyogenes
  • Chlamydophila pneumoniae
  • Flavobacterium columnare
  • Serratia marcescens
  • Klebsiella aerogenes
  • Campylobacter jejuni
  • Listeria monocytogenes
  • Shigella dysenteriae
Multi Drug-Resistant Bacteria
  • Penicillin-Resistant Streptococcus pneumoniae (PRSP)
  • Vancomycin-Resistant Enterococcus faecalis (VRE)
  • Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP)
  • Multidrug-Resistant (Carbapenem-Resistant Acinetobacter baumannii (MRAB/ CRAB)
  • NDM-1 New Delhi metallo-beta-lactamase
  • Vancomycin-Intermediate Staphylococcus aureus (VISA)
  • Methicillin-resistant Staphylococcus epidermidis (MRSE)
  • Multi-Drug Resistant Pseudomonas aeruginosa
Mycobacterium
  • Mycobacterium tuberculosis var: bovis
Pathogenic Fungi
  • Candida albicans
  • Candida auris
Non-enveloped Viruses
  • Adenovirus Type 2
  • Human Norovirus
  • Feline calicivirus
  • Human Rotavirus
  • Enterovirus Type 71
  • Echovirus Type 11
  • Human Adenovirus Type 5
  • Rhinovirus Type 1A
Enveloped Viruses
  • Herpes simplex virus Type 1
  • Herpes simplex virus Type 2
  • lnfluenza A virus
  • lnfluenza B virus
  • Parainfluenza virus Type 3
  • Human orthopneumovirus (Respiratory Syncytial Virus)
  • SARS-associated Coronavirus
  • Measles virus
  • Hepatitis B Virus (HBV)
  • Human Hepatitis C virus (HCV)
  • Human lmmunodeficiency virus Type 1 (HlV-1)
  • Cytomegalovirus (CMV)
  • Varicella Zoster Virus (VZV)(Human Herpes Type 3)
  • Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)

Ordering Information

CaviWipes 2.0 (6" x 6.75") - 160 Towelettes per Canister, 12 Canisters/Case

SKU 11-1410

CaviWipes 2.0 XL (9" x 12") - 160 Towelettes per Canister, 12 Canisters/Case

SKU 11-1450

Wipe Wall Bracket - 12 Brackets/Case

SKU 13-1175

Resources

Click here to see all product related information and resources.

Safety Data Sheets (SDS)

CaviWipes 2.0 Canada French SDS

Safety Data Sheets (SDS)

CaviWipes 2.0 US SDS

Sales Sheet

CaviWipes 2.0 Sales Sheet

Technical Document

CaviWipes 2.0 Technical Bulletin

Safety Data Sheets (SDS)

CaviWipes 2.0 - Product Label

Sales Sheet

CaviWipes 2.0 Sales Sheet

Related Products

  • CaviCide1™

    Fast and effective one step cleaner and disinfectant available in multiple configurations to help reduce the risk of cross-contamination with a 1 minute contact time.

  • CaviWipes™ Bleach

    Demonstrates effectiveness against over 40 relevant microorganisms. 1:10 Bleach dilution. No PPE required.

  • CaviWipes™

    3 Minute cleaner and disinfectant. Made of durable non-woven towelettes that offer quick easy-to-use convenience.